KATHERINE DOWLESS: Open Payments
NPI 1306610753 · WHITEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 70 payments from 19 companies in 2025. Trend: 2023 $122 · 2024 $2,134 · 2025 $1,449
Food & beverage: $1,449
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $302 |
| ABBVIE INC. | 15 | $238 |
| Novo Nordisk Inc | 7 | $209 |
| Amgen Inc. | 18 | $161 |
| Astellas Pharma US Inc | 1 | $124 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Abbott Laboratories | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: XIFAXAN, VRAYLAR, Wegovy, OTEZLA, Veozah, CAPLYTA, FREESTYLE LIBRE 3, Auvelity.
Industry payments across NC — which companies pay providers there.
